Kuwait Life Sciences (KLSC) was established in 2010, with a paid up capital of 15 million Kuwait Dinars (KD) which is equivalent to approximately $53 million US Dollars. KLSC is fully owned by National Technology Enterprises Company. National Technology Enterprises Company (NTEC) was incorporated in November of 2002, by the Kuwait Council of Ministers as a fully owned company by the Kuwait Investment Authority (KIA), the sovereign wealth fund of the State of Kuwait. Capitalized at 100 million Kuwait Dinars (KD) which is equivalent to approximately $350 million US Dollars, NTEC aims to play a vital role in servicing major stakeholders in Kuwait and the Middle East region with their technology requirements.
KLSC focuses on healthcare innovative concepts and demanded services which have a clear and unmet need in the Middle East and North Africa (MENA) region. KLSC has been designed as an integrated healthcare company building unique projects and is considered one of the pioneer venture capitalist and private equity companies in the Middle East that invests globally and operates regionally seeking to advance healthcare services and systems within the region. KLSC supports both public and private sector stakeholders to access emerging technologies, establish unique projects and adapt best practices prevailing in today’s healthcare field. KLSC operates in healthcare investment, life sciences training, medical technology and pharmaceutical distribution.
Industry
Venture Capital and Private Equity Principals
HQ Location
KIPCO Tower, 27th floor, Block 9, Al Shohadaa Street, Sharq
P.O.Box 25363 Safat
Kuwait, 13114, KW
Keywords
Venture Capital & Private EquityMiddle East Life Sciences OpportunitiesClinical Research Organization (CRO)Medical Devices & Diagnostics Commercializationand Advanced Healthcare Training CME/CPD